Thymosin Alpha-1 50mg — Vial Spec, Reconstitution Math & COA

Overview of Thymosin Alpha-1 50mg Research Vials

Thymosin Alpha-1 (TA1) is an endogenous 28-amino acid peptide derived from Prothymosin Alpha, widely evaluated in cell culture systems and animal models to examine pathway activation related to cell-mediated immune responses. The 50mg vial specification is tailored specifically for high-volume analytical testing, high-throughput automated cell assays, or large-scale preclinical trials where lot consistency across extended timelines is critical.

While standard single-assay protocols frequently utilize smaller sizes—such as our standard Thymosin Alpha-1 5mg vial—the 50mg presentation minimizes lot-to-lot variance during extensive multi-assay projects. Investigators seeking custom bulk fills, specialized packaging, or full microplate series preparations should evaluate whether high-capacity 50mg vials or multiple discrete 5mg vials best preserve working sample integrity during handling. For laboratories requiring custom bulk volumes or volume contract arrangements, details can be coordinated through our PX1 wholesale program.

Chemical Structure and Physical Properties

Thymosin Alpha-1 possesses the molecular formula C129H215N33O45 with a calculated molecular weight of approximately 3108.3 Da. The exact primary sequence is Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH. The N-terminal acetylation is a defining structural feature that protects the peptide against immediate exopeptidase degradation in native environments.

In its lyophilized form, PX1 Research Thymosin Alpha-1 presents as a dense, white-to-off-white cake. It demonstrates high solubility in aqueous buffer systems, including sterile bacteriostatic water, phosphate-buffered saline (PBS, pH 7.4), and standard laboratory diluents. Due to the high mass concentration in a 50mg vial, precise volumetric calculations are essential to prevent supersaturation or precipitation during reconstitution.

Reconstitution Math for a 50mg Lyophilized Mass

Reconstitution of a 50mg mass requires careful volume selection based on intended target concentrations for laboratory equipment. Because 50mg represents a substantial peptide mass, using low diluent volumes results in highly concentrated stock solutions that require complete mixing without mechanical shear. Investigators can use our online reconstitution calculator to verify custom laboratory volume math.

When reconstituting a 50mg vial with 1.0 mL of laboratory diluent, the resulting stock concentration is exactly 50 mg/mL (50 µg/µL). Adding 2.0 mL yields a stock concentration of 25 mg/mL (25 µg/µL), while 3.0 mL yields approximately 16.67 mg/mL (16.67 µg/µL). If standard assay working solutions require lower microgram-level working stocks, secondary serial dilutions in sterile assay buffer should be performed immediately following initial solubilization.

Aliquot Planning and Degradation Control

Because reconstituted peptide solutions degrade under repeated freeze-thaw cycles, reconstituting a single 50mg vial into a master solution without immediate aliquoting risk compromising structural integrity over time. Repeated thermal fluctuations induce aggregation, peptide cleavage, and loss of biological activity in cell-culture models.

Upon full dissolution of the 50mg cake, the stock solution should be divided into single-use micro-aliquots using sterile, polypropylene low-binding microcentrifuge tubes. Aliquots designated for short-term use (1–7 days) may be stored at 2°C to 8°C if prepared with bacteriostatic diluents. Aliquots intended for long-term storage must be flash-frozen and kept at -20°C or -80°C. Once thawed, an individual aliquot should never be refrozen.

Lot-Matched Certificate of Analysis (COA) Standards

Every batch of Thymosin Alpha-1 produced for PX1 Research undergoes rigorous third-party analytical testing in an ISO 17025 accredited laboratory. Quality verification includes High-Performance Liquid Chromatography (HPLC) to confirm chemical purity and Mass Spectrometry (MS) to verify precise molecular weight matching the theoretical mass of 3108.3 Da.

Because high-concentration research applications require minimal background interference, PX1 mandates a minimum HPLC purity threshold of ≥98.0%. In addition, bacterial endotoxin testing (LAL assay) confirms endotoxin levels remain below strict threshold limits (<0.01 EU/mg), ensuring compatibility with sensitive cell cultures. Laboratory directors can download transparent, lot-matched documentation directly via our COA lookup portal.

Preclinical Biological Mechanisms and Pathway Research

Preclinical studies suggest that Thymosin Alpha-1 exerts biological effects primarily through interaction with Toll-like receptors (TLR-7 and TLR-9) on dendritic cell populations. In vitro data indicate that signal transduction through these innate immune receptors triggers the downstream activation of Nuclear Factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways.

In cell culture models, TA1 exposure has been observed to modulate cytokine secretion profiles, specifically increasing expression of Interleukin-2 (IL-2), Interleukin-12 (IL-12), and Interferon-gamma (IFN-γ). Additional preclinical animal models explore TA1 influence on T-cell lineage maturation, major histocompatibility complex (MHC-I) surface expression, and natural killer (NK) cell cytotoxic activity. Researchers analyzing immune signal cascades can explore related findings in our peptide research hub.

Comparative Analysis: Immunomodulatory & Signaling Research Compounds

Within preclinical literature, Thymosin Alpha-1 is frequently compared against other signaling peptides to evaluate distinct signaling cascades and cellular responses. While TA1 operates predominantly through TLR-mediated pathway activation and T-cell differentiation markers, compounds like Thymosin Beta-4 regulate actin-sequestering mechanisms and cell migration pathways. Meanwhile, peptides such as LL-37 demonstrate direct antimicrobial membrane perturbation alongside immune signaling, and BPC-157 is examined primarily in tissue repair and endothelial growth factor expression models. Evaluating these distinct mechanism profiles allows researchers to select the precise molecular tool required for targeted pathway investigation.

Selecting the Optimal Specification: 50mg vs 5mg Vials

Determining whether to acquire a high-capacity 50mg vial or multiple smaller units depends on experimental scale and handling capabilities. A single 50mg vial offers operational efficiency for high-throughput screening where large master mixes are prepared in a single session. This reduces vial-to-vial handling steps and ensures uniform peptide concentration across thousands of assay wells.

Conversely, laboratories performing periodic, low-volume assays over several months often benefit from smaller packaging formats, such as our standard Thymosin Alpha-1 5mg packaging. Utilizing smaller discrete vials mitigates the risk of degradation associated with extended storage of reconstituted master stocks. Browse our full catalog of research compounds at /all-peptides to determine the ideal vial configuration for your laboratory schedule.

Laboratory Handling, Solubilization, and Reconstitution Protocol

To maintain optimal stability when handling Thymosin Alpha-1 50mg vials, technical personnel should follow strict aseptic laboratory practices. Allow the lyophilized vial to equilibrate to room temperature before reconstitution to prevent moisture condensation inside the vial upon opening.

Direct the chosen diluent—such as sterile Bacteriostatic Water—against the glass wall of the vial rather than shooting directly onto the lyophilized cake. Gently swirl the vial in a circular motion until the peptide is fully dissolved. Do not vortex or agitate vigorously, as mechanical shear forces can cause polypeptide chain denaturation or physical aggregation.

PX1 Research Quality Assurance & US Supply Infrastructure

PX1 Research is committed to supplying synthesized research compounds manufactured under strict GMP-compliant quality management standards. Every lot of Thymosin Alpha-1 is synthesized in USA-based facilities and verified by independent ISO 17025 laboratories to guarantee identity, purity, and low endotoxin burdens.

To protect compound stability during transport, PX1 fulfills orders directly from our dedicated climate-controlled dispatch centers in California and Arizona. Orders placed Monday through Friday before cut-off times ship same-day, ensuring reliable delivery timelines for critical research schedules.